ARTICLE | Company News
InterMune Pharmaceuticals Inc., Boehringer Ingleheim GmbH deal
April 2, 2001 7:00 AM UTC
ITMN will develop and market interferon gamma-1b under Boehringer's trade name Imukin in all countries outside of the U.S., Canada and Japan. ITMN already has rights to develop and market interferon g...